site stats

Sphere peraf trial

WebJan 10, 2024 · Affera designs and manufactures cardiac mapping and navigation systems and catheter-based cardiac ablation technologies, including a differentiated, focal pulsed field ablation solution, for the treatment of patients with cardiac arrhythmias (irregular heartbeats) such as atrial fibrillation (AF). WebDec 20, 2024 · First patient treated in US IDE SPHERE PerAF at @MountSinaiNYC by Drs. @VivekReddyMD @jskoruth @billwhangep and others. Affera also announces $75M series C with Bain Capital Life Sciences.

Affera Announces First Patient Treated in SPHERE Per-AF IDE …

WebThe SPHERE PerAF trial uses pulsed field ablation to normalize an irregular heartbeat and is the first randomized catheter ablation IDE trial to treat persistent atrial fibrillation. The … WebDec 20, 2024 · NEWTON, Mass., Dec. 20, 2024 /PRNewswire/ -- Affera Inc., a private medical device company focused on innovative cardiac arrhythmia treatment solutions, … the ship busselton https://mcseventpro.com

Medtronic to Acquire Affera - Jan 10, 2024

WebCongratulations to the Sentara team members who successfully completed our first patient procedure in the recently approved SPHERE PerAF Trial! This clinical trial will evaluate the safety and ... WebJan 10, 2024 · In December 2024, Affera announced the commencement of the recently approved SPHERE PerAF Trial, a US Food and Drug Administration (FDA) Investigational Device Exemption (IDE) pivotal randomised trial, to evaluate the safety and effectiveness of the Affera system for the treatment of persistent AF. WebFirst Patient Treated in SPHERE PerAF Trial December 21st, 2024 Professional Memberships American College of Cardiology - ACC Member Hospital Affiliations Morristown Medical CenterMorristown, New Jersey Viewing the full profile is available to verified healthcare professionals only. Find your profile and take control of your online … my skin laser clinic

Medtronic to Acquire Affera - Cardiac Vascular News

Category:Medtronic completes enrollment in pivotal trial evaluating …

Tags:Sphere peraf trial

Sphere peraf trial

Medtronic to Acquire Affera - Innogest

WebDec 20, 2024 · Affera is developing a comprehensive integrated platform to efficiently deliver durable therapy for a broad set of cardiac arrhythmia patients. The Affera system … WebDec 20, 2024 · The Affera system includes the Sphere-9™ catheter and integrated Prism-1™ mapping system to enable the rapid creation of detailed maps, as well as the versatile …

Sphere peraf trial

Did you know?

WebNov 15, 2024 · Treatment of Persistent Atrial Fibrillation With Sphere-9 Catheter and Affera Mapping and Ablation System (SPHERE Per-AF) The safety and scientific validity of this … WebJan 10, 2024 · Affera designs and manufactures cardiac mapping and navigation systems and catheter-based cardiac ablation technologies, including a differentiated, focal pulsed …

WebDec 5, 2024 · The SPHERE Per-AF Trial is a global, prospective, multicenter, randomized clinical trial. Since the trial's commencement in December 2024, the trial enrolled 477 … Web• Mapping Specialist for Mass. General, Mount Sinai, Cleveland Clinc, and Lenox Hill Hospitals for the Pivotal Sphere PerAF trial which completed enrollment of over 400 patients in one year

WebDec 20, 2024 · NEWTON, Mass. , Dec. 20, 2024 /PRNewswire/ — Affera Inc., a private medical device company focused on innovative cardiac arrhythmia treatment solutions, announced today that the first patient was treated in the recently approved SPHERE PerAF Trial, a U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) … WebJan 10, 2024 · Affera designs and manufactures cardiac mapping and navigation systems and catheter-based cardiac ablation technologies, including a differentiated, focal pulsed …

WebIn December 2024, Affera announced the commencement of the recently approved SPHERE PerAF Trial, a U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) pivotal randomized trial, to evaluate the safety and effectiveness of the Affera system for the treatment of persistent AF. Affera's product portfolio is not currently ... the ship bykerWebMay 4, 2024 · In December 2024, Affera announced the commencement of the SPHERE PerAF trial, a US FDA investigational device exemption pivotal randomized study, to evaluate the safety and effectiveness of the Affera system for … the ship by henry van dykeWebJan 10, 2024 · The Affera full-suite of solutions and technologies will complement the existing Medtronic atrial and ventricular arrhythmia disease management portfolio and … my skin laser head officeWebJan 10, 2024 · Affera recently celebrated t he first patient to be treated with its technology in New York. Last month, the company announced that it had received FDA approval to … my skin looks dry with makeupWebJan 10, 2024 · Affera designs and manufactures cardiac mapping and navigation systems and catheter-based cardiac ablation technologies, including a differentiated, focal pulsed … my skin itches everywhereWebJan 28, 2024 · The PerAF APAC trial is a prospective, single arm, non-randomized, observational, post-market clinical investigation. Approximately 100 subjects will be enrolled at up to 15 sites in South Korea, Singapore, Hong Kong, Taiwan, and India. Centers in other countries within APAC may be approached for participation in the clinical investigation as ... my skin matters productsWebJan 10, 2024 · Affera designs and manufactures cardiac mapping and navigation systems and catheter-based cardiac ablation technologies, including a differentiated, focal pulsed field ablation solution, for the... my skin northcote